Gene search


Sequence information


Select Gene Cds Cds_length GC_content Pep Pep_length
Apr8g2216 ATGGCTTTACCCTTCAACCTCGTAATCTCGTACCTTGTCGCGTTCCACTTGTTCTGCGCCATTGCAGACCAAAACCCAGAAATAACTTCCCTCCTTTCCTTCAAGGAGGGTCTTCAAAACCCTAAACTTCTCGCTTCGTGGCACCCCTCCACCTCGCACTGCAACTGGGTCGGCGTCACGTGTCAACTCGGTCGAGTCACCTCGCTTTCTCTTCCATCTCTTTCCCTCAGTGGCACACTTCCTTCGCCCCTTTTCTCTCTCTCCTCACTCACTCTTCTCAACCTCGGTGACAACCAGCTTTCTGGCGAGCTTCCCGGCGAACTCGGCGAATTAGTTCAGCTTGAAACTCTTCGACTCGGTTCCAACTCGTTCGCCGGAAAAATCCCGCCGGAGCTGGGGTTATTGGCGAAACTCCGCACTCTCGACCTCTCTGGCAATGCACTCGCCGGAGAAATACCGGAGACTCTAGGAAACTTGAGCCGGCTTGAGTTCATGGACTTTAGTAACAACCTCCTCTCAGGTTCTCTTCCGATAACTCTCTTCACCGGAACTCAGTCTTTGATTTCTGTTGATATCTCGAACAACTCGTTTTCCGGCGTTCTGCCGCCGGAAATTGGGAACTGGAAGAACATCAGTGCACTTTACCTGGGGATTAACAAGTTGTCGGGTACGTTGCCGAAGGAAATTGGGAAGCTCTCGAGGCTTGAAATTTTGTATGCACCTTCCTGTTCCATCGAAGGTCCTTTGCCTGACGAAATGGCAGAGCTGAAGTCGTTGGCCAAGCTTGACCTTTCTTACAACCCGTTGAGATGTTCGATCCCAAAGTTTATTGGGAAGTTGCAGAATTTGAAAATTTTGAATCTTGTGTTTGCTCAGCTTAATGGGTCAGTGCCACCTGAGTTTGGGAATTGTAAGAGCCTGAGGTCTATGATGCTTTCTTTCAATTCACTTTCTGGCTTACTGCCCGAGGAGCTTTCTGAGCTCCCAATAATAACATTTTCAGCTGAAAAAAATCAGATTCATGGGCCTTTGCCTTCTTGGCTGGGAAAGTGGACTGATGTTAATTCTCTTTTGCTTTCTTCTAACCGTTTTTCTGGGGTGATTCCACCTCAACTTGGGAATTGCTCTGCAATGCAGCACCTTAGTTTAAGCAGTAATTTGTTGACTGGTCCCATACCTGAGGAGCTTTGTAAAGCTGCCTCACTTGTGGATATTGATCTTGATGACAACTTCCTTTCTGGTACAATTGAGAAAGCATTTGTCAAGTGTAAGAACCTTACCCAGTTGGTTTTGATGAACAATAGGGTTGTCGGTTCTATACCACAGTACCTTTCAGAGCTTCCCTTGATGGTGCTGGACCTGGATTCTAACAATTTTAGTGGAAAAATACCTTCTAGTCTTTGGAACTCATCAACTCTGTTGGAATTCTCTGCAGCTAATAACCGTTTGGAGGGGTCTCTTCCTGTGGAGATTGGGAATGTGGTTAGTCTACAGAGGCTTGTTCTTAGCAATAATAGACTGACAGGTACTATACCTAAGGAAATTGGAAGTCTCACAAGTCTTTCAGTTCTTAATTTGAATGGGAATATGCTTGAAGGGAATATTCCCACTGAGCTTGGTGATTGCATTTCCCTTACTACACTGGACCTTGGGAACAATCAACTCAAAGGGTCTATTCCTGAGAAGCTGGTGGAGCTAAGCCAATTACAGTGCTTGGTTCTTTCTCACAATAATCTGTCTGGGTCTATTCCTGCCAAGAAATCTTCATATTTTCGACAACTCACCATCCCTGACTTGAGCTTTGTTCAACACCTTGGTGTGTTTGATCTTTCTCACAATAGATTGTCTGGCACCATTCCTGATGAATTGGGGAGCTGTGTAGTGATTGTGGATCTCTTAGTTAGCAACAACATGCTTTCTGGGAGCATTCCAAGATCACTGGCACGCTTGACAAATCTTACAACTTTGGATTTGTCTAGCAACTTCTTGTCAGGTTCCATTCCATCAGAGCTTGGAGATGCCCTCAAACTCCAGGGTTTGTATCTGGGACAGAATCAACTATCAGGTACCATCCCTGAAAGTTTTGGGAAGTTGAGTAGTTTGGTGAAGCTGAATTTGACAGGAAATAAGTTGTCGGGTCCAATCCCAATTAGTTTTGGGAACATGAAGGAGTTGACTCACTTGGATTTGAGCTCTAATGAGCTCAGTGGTCAGCTTCCATCCTCTCTGTCAGGGGTGCAAAGCCTTGTTGGGCTTTATGTGCAGAAGAACAGGCTTTCTGGCCAAGTAGGGGACCTCTTCTCCAACTCCATGACATGGAGAATTGAGACAATGAATTTAAGTGATAATTGCTTCAACGGGAACTTGCCACGGTCTTTGGGAAATCTTTCTTACTTGACAAATTTGGATCTTCATGGAAATATGTTGACTGGACAGATTCCTTTAGACCTTGGGGATCTAATGCAATTGGAATATTTTGATGCTTCAGGTAATCAGCTAACTGGAAGGATTCCAGAGAAGCTATGCAGCCTAGTTAATCTGAACTACCTAGATTTGTCTCAAAACAGATTGGAAGGACCTATACCTAAAAGTGGTATTTGCCAAAACCTATCCAGAGTTAGATTTGTGGGGAACAAAAATCTTTGTGGCCAGTTGTTGGGTATAATTTGTCAGACCAAAAGCATTGGTAGATCAGCATTGTTTAATGCGTGGAGGCTTGCTGCAATTGCCATTACAATCATTTTACTAACTCTAAGCATTGCTTTTGTTCTACATAGATGGATTACCAGGAGGCAAAATGATCCTGAGGAGCTTGAGGAGCGCAAATTAAACAGTTATGTAGATCACAATCTTTATTTCTTGAGCAGTAGTAGATCAAAGGAACCTTTGAGTATCAATGTTGCAATGTTTGAGCAGCCTCTTCTGAAATTAACTTTGGTGGATATCCTTGAAGCCACTGACAACTTCAGCAAGACAAATATTATTGGAGACGGAGGCTTTGGAACTGTGTACAAGGCCACTTTACCTGATGGAAAAACAGTAGCTGTGAAGAAGCTTAGTGAAGCTAAAACGCAGGGTAATCGTGAGTTCATGGCTGAAATGGAGACCTTGGGCAAGGTGAAGCATCAAAATCTTGTTGCGTTGCTTGGATATTGCTCAATGGGCGATGAAAAACTCCTTGTTTACGAATATATGGTAAATGGGAGCTTAGATCTTTGGTTGAGAAATAGGACTGGGGCCCTTGAAATCCTTGACTGGAACAAACGTTACAAAATTGCAACCGGCGCAGCCCGAGGATTAGCTTTCCTTCATCATGGTTTCATACCTCACATCATCCACAGGGATGTTAAAGCTAGCAACATTTTACTCAATGAAGACTTTGAGCCAAAAGTTGCAGATTTTGGACTTGCAAGACTAATCAGTGCCTGTGAGACTCATATCACCACTGATATAGCTGGAACATTTGGTTACATTCCACCAGAGTATGGGCAGAGTGGGAGGTCCACAACAAGAGGAGATGTGTACAGTTTTGGTGTCATTTTACTTGAACTAGTGACTGGAAAAGAGCCAACTGGACCAGATTTTAAGGAGATTGAAGGTGGAAACTTGGTTGGATGGGTTAGTCAGAAGATCAAGAAGGGGCAAGCTGCTGATGTTCTTGATCCAACAGTTCTTGATGCTGATTCTAAGCAGATGATGCTTCAAATGCTGCACATTGCTTGTGTATGCCTCTCTGACAATCCTGCAAACAGGCCTACCATGCTTCAAGTACACAAATTCTTGAAGGGGATTAAGGGAGAGTAG 3804 0.4409 MALPFNLVISYLVAFHLFCAIADQNPEITSLLSFKEGLQNPKLLASWHPSTSHCNWVGVTCQLGRVTSLSLPSLSLSGTLPSPLFSLSSLTLLNLGDNQLSGELPGELGELVQLETLRLGSNSFAGKIPPELGLLAKLRTLDLSGNALAGEIPETLGNLSRLEFMDFSNNLLSGSLPITLFTGTQSLISVDISNNSFSGVLPPEIGNWKNISALYLGINKLSGTLPKEIGKLSRLEILYAPSCSIEGPLPDEMAELKSLAKLDLSYNPLRCSIPKFIGKLQNLKILNLVFAQLNGSVPPEFGNCKSLRSMMLSFNSLSGLLPEELSELPIITFSAEKNQIHGPLPSWLGKWTDVNSLLLSSNRFSGVIPPQLGNCSAMQHLSLSSNLLTGPIPEELCKAASLVDIDLDDNFLSGTIEKAFVKCKNLTQLVLMNNRVVGSIPQYLSELPLMVLDLDSNNFSGKIPSSLWNSSTLLEFSAANNRLEGSLPVEIGNVVSLQRLVLSNNRLTGTIPKEIGSLTSLSVLNLNGNMLEGNIPTELGDCISLTTLDLGNNQLKGSIPEKLVELSQLQCLVLSHNNLSGSIPAKKSSYFRQLTIPDLSFVQHLGVFDLSHNRLSGTIPDELGSCVVIVDLLVSNNMLSGSIPRSLARLTNLTTLDLSSNFLSGSIPSELGDALKLQGLYLGQNQLSGTIPESFGKLSSLVKLNLTGNKLSGPIPISFGNMKELTHLDLSSNELSGQLPSSLSGVQSLVGLYVQKNRLSGQVGDLFSNSMTWRIETMNLSDNCFNGNLPRSLGNLSYLTNLDLHGNMLTGQIPLDLGDLMQLEYFDASGNQLTGRIPEKLCSLVNLNYLDLSQNRLEGPIPKSGICQNLSRVRFVGNKNLCGQLLGIICQTKSIGRSALFNAWRLAAIAITIILLTLSIAFVLHRWITRRQNDPEELEERKLNSYVDHNLYFLSSSRSKEPLSINVAMFEQPLLKLTLVDILEATDNFSKTNIIGDGGFGTVYKATLPDGKTVAVKKLSEAKTQGNREFMAEMETLGKVKHQNLVALLGYCSMGDEKLLVYEYMVNGSLDLWLRNRTGALEILDWNKRYKIATGAARGLAFLHHGFIPHIIHRDVKASNILLNEDFEPKVADFGLARLISACETHITTDIAGTFGYIPPEYGQSGRSTTRGDVYSFGVILLELVTGKEPTGPDFKEIEGGNLVGWVSQKIKKGQAADVLDPTVLDADSKQMMLQMLHIACVCLSDNPANRPTMLQVHKFLKGIKGE* 1268
       

Annotation information


Select Seq ID Length Analysis Description Start End IPR GO
Apr8g2216 1267 SUPERFAMILY L domain-like 29 272 - -
Apr8g2216 1267 Gene3D Ribonuclease Inhibitor 24 181 IPR032675 -
Apr8g2216 1267 PANTHER UNNAMED PRODUCT 604 1265 - -
Apr8g2216 1267 PANTHER UNNAMED PRODUCT 108 271 - -
Apr8g2216 1267 PANTHER UNNAMED PRODUCT 423 671 - -
Apr8g2216 1267 PANTHER UNNAMED PRODUCT 333 606 - -
Apr8g2216 1267 PANTHER UNNAMED PRODUCT 23 238 - -
Apr8g2216 1267 PANTHER UNNAMED PRODUCT 172 441 - -
Apr8g2216 1267 Gene3D Phosphorylase Kinase; domain 1 952 1064 - -
Apr8g2216 1267 ProSiteProfiles Protein kinase domain profile. 989 1261 IPR000719 GO:0004672|GO:0005524|GO:0006468
Apr8g2216 1267 SMART LRR_sd22_2 542 568 - -
Apr8g2216 1267 SMART LRR_sd22_2 135 161 - -
Apr8g2216 1267 SMART LRR_sd22_2 722 748 - -
Apr8g2216 1267 SMART LRR_sd22_2 650 673 - -
Apr8g2216 1267 SMART LRR_sd22_2 796 817 - -
Apr8g2216 1267 SMART LRR_sd22_2 844 872 - -
Apr8g2216 1267 Pfam Leucine rich repeat N-terminal domain 25 61 IPR013210 -
Apr8g2216 1267 SUPERFAMILY L domain-like 591 883 - -
Apr8g2216 1267 PANTHER LEUCINE-RICH REPEAT RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED 172 441 - -
Apr8g2216 1267 PANTHER LEUCINE-RICH REPEAT RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED 333 606 - -
Apr8g2216 1267 PANTHER LEUCINE-RICH REPEAT RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED 108 271 - -
Apr8g2216 1267 PANTHER LEUCINE-RICH REPEAT RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED 604 1265 - -
Apr8g2216 1267 PANTHER LEUCINE-RICH REPEAT RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED 23 238 - -
Apr8g2216 1267 PANTHER LEUCINE-RICH REPEAT RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED 423 671 - -
Apr8g2216 1267 SUPERFAMILY Protein kinase-like (PK-like) 970 1261 IPR011009 -
Apr8g2216 1267 SMART LRR_typ_2 159 183 IPR003591 -
Apr8g2216 1267 SMART LRR_typ_2 722 745 IPR003591 -
Apr8g2216 1267 SMART LRR_typ_2 518 542 IPR003591 -
Apr8g2216 1267 SMART LRR_typ_2 543 566 IPR003591 -
Apr8g2216 1267 SMART LRR_typ_2 844 869 IPR003591 -
Apr8g2216 1267 SMART LRR_typ_2 796 820 IPR003591 -
Apr8g2216 1267 SMART LRR_typ_2 650 674 IPR003591 -
Apr8g2216 1267 SMART LRR_typ_2 494 517 IPR003591 -
Apr8g2216 1267 SMART LRR_typ_2 602 626 IPR003591 -
Apr8g2216 1267 SMART LRR_typ_2 87 111 IPR003591 -
Apr8g2216 1267 SMART LRR_typ_2 698 721 IPR003591 -
Apr8g2216 1267 SMART LRR_typ_2 256 280 IPR003591 -
Apr8g2216 1267 SMART LRR_typ_2 135 158 IPR003591 -
Apr8g2216 1267 Gene3D Ribonuclease Inhibitor 398 470 IPR032675 -
Apr8g2216 1267 Gene3D Ribonuclease Inhibitor 332 397 IPR032675 -
Apr8g2216 1267 Pfam Leucine Rich Repeat 725 745 IPR001611 GO:0005515
Apr8g2216 1267 Pfam Leucine Rich Repeat 137 159 IPR001611 GO:0005515
Apr8g2216 1267 SMART serkin_6 989 1261 IPR000719 GO:0004672|GO:0005524|GO:0006468
Apr8g2216 1267 ProSitePatterns Protein kinases ATP-binding region signature. 995 1018 IPR017441 GO:0005524
Apr8g2216 1267 Gene3D Transferase(Phosphotransferase) domain 1 1065 1267 - -
Apr8g2216 1267 PRINTS Leucine-rich repeat signature 725 738 - -
Apr8g2216 1267 PRINTS Leucine-rich repeat signature 844 857 - -
Apr8g2216 1267 Gene3D Ribonuclease Inhibitor 471 591 IPR032675 -
Apr8g2216 1267 SUPERFAMILY L domain-like 272 366 - -
Apr8g2216 1267 ProSitePatterns Serine/Threonine protein kinases active-site signature. 1111 1123 IPR008271 GO:0004672|GO:0006468
Apr8g2216 1267 Gene3D Ribonuclease Inhibitor 592 893 IPR032675 -
Apr8g2216 1267 Gene3D Ribonuclease Inhibitor 182 331 IPR032675 -
Apr8g2216 1267 SUPERFAMILY L domain-like 336 600 - -
Apr8g2216 1267 Pfam Leucine rich repeat 651 711 IPR001611 GO:0005515
Apr8g2216 1267 Pfam Protein kinase domain 990 1258 IPR000719 GO:0004672|GO:0005524|GO:0006468
       

Duplication type information


Select Gene Chromosome Start End Duplicated_type
Apr8g2216 Apr-Chr8 32613790 32617643 Dispersed/Transposed
       

Functional genes information


Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Apr8g2216 21 1264 Receptor kinase-like Gene Family AT5G07280 60.480 0.0 1442
       

Transcription factors information


Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
PK RLK-Pelle_LRR-Xb-1 Apr8g2216 Pkinase 2.2e-46 CL0016
       

Pathway information


Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Apr8g2216 - - gmx:100780446 2156.72